The Magnificence Overall health Company (NASDAQ:Skin – Get Score) has acquired an average recommendation of “Buy” from the twelve ratings firms that are presently masking the stock, Marketbeat.com experiences. A person investment decision analyst has rated the inventory with a keep recommendation and eleven have offered a invest in suggestion to the firm. The ordinary 12-thirty day period rate concentrate on amongst analysts that have coated the stock in the last 12 months is $27.90.
Pores and skin has been the topic of a amount of new analyst experiences. William Blair initiated protection on shares of Natural beauty Overall health in a report on Friday, January 7th. They set an “outperform” ranking on the stock. Benchmark upped their goal price tag on shares of Splendor Overall health from $18.00 to $23.00 and gave the inventory a “buy” ranking in a report on Monday, March 14th. Zacks Investment decision Investigate lifted shares of Elegance Health and fitness from a “hold” rating to a “buy” rating and established a $21.00 concentrate on price for the firm in a report on Saturday, February 26th. DA Davidson improved their cost objective on shares of Magnificence Wellbeing from $32.00 to $35.00 and gave the enterprise a “buy” rating in a report on Wednesday, February 23rd. Last but not least, JPMorgan Chase & Co. commenced protection on shares of Elegance Overall health in a investigate report on Friday, March 11th. They established an “overweight” ranking and a $24.00 concentrate on price tag on the inventory.
Pores and skin opened at $13.32 on Wednesday. The stock’s 50 day basic transferring average is $16.54 and its 200 day uncomplicated relocating common is $20.19. Beauty Well being has a 1 calendar year very low of $9.91 and a 1 yr higher of $30.17. The corporation has a financial debt-to-fairness ratio of 2.41, a fast ratio of 12.63 and a existing ratio of 13.09.
Beauty Health and fitness (NASDAQ:Pores and skin – Get Ranking) previous issued its quarterly earnings facts on Tuesday, February 22nd. The corporation documented $.01 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($.03) by $.04. The firm had earnings of $77.90 million for the duration of the quarter, when compared to the consensus estimate of $70.90 million. The business’s profits was up 106.1% on a year-in excess of-year basis. Analysts hope that Elegance Health and fitness will post .09 EPS for the recent fiscal 12 months.
Institutional investors have not too long ago purchased and bought shares of the corporation. PNC Monetary Solutions Team Inc. elevated its posture in shares of Magnificence Wellbeing by 47.5% in the 3rd quarter. PNC Money Companies Group Inc. now owns 1,962 shares of the company’s stock valued at $50,000 right after purchasing an further 632 shares in the very last quarter. Logan Cash Management Inc. purchased a new stake in shares of Splendor Wellbeing in the third quarter valued at around $78,000. Lindbrook Cash LLC purchased a new stake in shares of Natural beauty Wellbeing in the fourth quarter valued at close to $74,000. First Mercantile Rely on Co. acquired a new stake in shares of Attractiveness Health in the 3rd quarter valued at roughly $82,000. Ultimately, Nisa Financial investment Advisors LLC bought a new stake in shares of Elegance Wellness in the fourth quarter valued at about $47,000. Institutional traders and hedge resources possess 62.99% of the company’s stock.
Splendor Health and fitness Organization Profile (Get Score)
The Magnificence Overall health Firm layouts, develops, manufactures, markets, and sells aesthetic technologies and merchandise globally. The company’s flagship product involves HydraFacial that increase the pores and skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the pores and skin with proprietary methods and serums.
Receive News & Ratings for Attractiveness Health Everyday – Enter your electronic mail tackle beneath to get a concise day-to-day summary of the hottest news and analysts’ ratings for Magnificence Overall health and associated providers with MarketBeat.com’s Free each day email newsletter.